Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Briviact 50mg/5ml solution for injection vials
0408010ALBBAFAF
|
Briviact | Brivaracetam | Central Nervous System | No data available |
|
Broflex 5mg/5ml syrup
0409020C0BCAAAC
|
Broflex | Trihexyphenidyl hydrochloride | Central Nervous System | No data available |
|
Bromazepam 3mg tablets
0401020G0AAAAAA
|
Bromazepam | Bromazepam | Central Nervous System | No data available |
|
Buccastem 3mg tablets
0406000T0BDAAAK
|
Buccastem | Prochlorperazine maleate | Central Nervous System | No data available |
|
Bunov 15micrograms/hour transdermal patches
0407020B0BUADAK
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Bunov 30micrograms/hour transdermal patches
0407020B0BUAEAM
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Bunov 40micrograms/hour transdermal patches
0407020B0BUAFAN
|
Bunov | Buprenorphine | Central Nervous System | No data available |
|
Buplast 52.5micrograms/hour transdermal patches
0407020B0BNABAF
|
Buplast | Buprenorphine | Central Nervous System | No data available |
|
Buprenorphine 1.4mg / Naloxone 360microgram SL tab SF
0410030B0AAAGAG
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 11.4mg / Naloxone 2.9mg SL tab sugar free
0410030B0AAAJAJ
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 1mg sublingual tablets sugar free
0410030A0AAAIAI
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 2.9mg / Naloxone 710microgram SL tab SF
0410030B0AAAHAH
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 300micrograms/1ml inj ampoules
0407020B0AAAAAA
|
Buprenorphine (Opioid Analgesic) | Buprenorphine | Central Nervous System | No data available |
|
Buprenorphine 4mg sublingual tablets sugar free
0410030A0AAAKAK
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 6mg sublingual tablets sugar free
0410030A0AAAJAJ
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 74.2mg implant
0410030A0AAAWAW
|
Buprenorphine (Opioid Dependance) | Buprenorphine hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8.6mg / Naloxone 2.1mg SL tab sugar free
0410030B0AAAFAF
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Buprenorphine 8mg / Naloxone 2mg sublingual films sugar free
0410030B0AAAEAE
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | No data available |
|
Busiete 10micrograms/hour transdermal patches
0407020B0BRABAI
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 20micrograms/hour transdermal patches
0407020B0BRACAJ
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Busiete 5micrograms/hour transdermal patches
0407020B0BRAAAH
|
Busiete | Buprenorphine | Central Nervous System | No data available |
|
Buspar 10mg tablets
0401020B0BBABAB
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
|
Buspar 5mg tablets
0401020B0BBAAAA
|
Buspar | Buspirone hydrochloride | Central Nervous System | No data available |
|
Byannli 1000mg/5ml prolonged-release inj pf syringes
0402020ABBDABAJ
|
Byannli | Paliperidone | Central Nervous System | No data available |
|
Cabaser 4mg tablets
0409010U0BBACAC
|
Cabaser | Cabergoline | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.